4Front Appoints Two New Board Members

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company“) today announced the appointment of Kathi Lentzsch, CEO and president of Bartell Drugs, and…

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company“) today announced the appointment of Kathi Lentzsch, CEO and president of Bartell Drugs, and Betty Aldworth, executive director of Students for Sensible Drug Policy, to its Board of Directors. “I’m excited to see our new board taking shape with the additions of Kathi Lentzsch and […]

The post 4Front Appoints Two New Board Members appeared first on Technical420.

Leave a Reply

Your email address will not be published. Required fields are marked *